Biosimilars manufacturing excellence
Discover how supplementing CHO cell cultures with high-quality Recombinant Insulin can improve and stabilize cell culture performance—ultimately driving higher monoclonal antibody (mAb) yields and lowering production costs.
Enhanced CHO-K1 culture with Recombinant Insulin
Recombinant insulin enhances CHO-K1 fed-batch culture performance and consistency while reducing costs in cell culture processes.
The cost-saving impact of Recombinant Insulin
Insulin infographics The cost-saving impact of Recombinant Insulin Solutions Realizing economic returns through improved productivity Explore the infographic below to see how the improved process performance achieved with Recombinant Insulin in cell culture, can translate into impressive cost savings for mAb production at both small and large production scales. Download the infographic in PDF format […]
Boost production of mAbs in CHO cells using Recombinant Insulin
Explore the infographic below to discover how Recombinant Insulin can result in up to a 1.7-fold increase in mAb production in CHO-S and CHO-K1 cells. Download the infographic in PDF format using the link at the bottom.
Recombinant Insulin CHO-S poster
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
